Want to join the conversation?
$NAVI 1Q15 10-Q: Restructuring and other reorganization expenses decreased $23MM to $3MM. These expenses were primarily related to costs incurred in connection with the Spin-Off. On April 30, 2014, the Spin-Off of Navient from SLM Corporation was completed and Navient became an independent, publicly-traded company.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.